FDA Investigator Amanda J White
Amanda J White has inspections in 8 countries as of 25 Aug 2023. Amanda J White has collaborated with a combined 2803 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
119
Last Inspection Date:
25 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
India,
Poland,
Germany,
Switzerland,
Italy,
Serbia,
Spain
Co-Investigator(s):
A Williams,
Abby Lmozeke Baker,
Adam C Hipko,
Adrian Rodriguez,
Alanna Lmussawwir Bias,
Albert F Peacock, PhD,
Amanda E Lewin, PhD,
Andrace Lde Yampert,
Andrea A Branche,
Anh M Lac,
Ann Marie Karnick,
Annette Melendez,
Anya D Lockett Evans,
Ashley N Williams,
Betsy C Galliher,
Bing Lin,
Blondell W Johnson,
Bobbi J Miller,
Brackens Harris,
Brandon K Barbee,
Brent Sexton,
Brian Sanders,
Brunilda Torres,
Camille D Brown,
Carol A Declouette Wilburn,
Cathleen A Castellaw,
Charles D Brown,
Chmura,
Christine L Williams,
Christopher D Rush,
Christopher J Hurst,
Christopher J Smith,
Christopher L Jacobs,
Connie L Hannon Rabel,
Courtney N Long,
Cymbre Weatherly,
Cynthia A Harris, MD, RN,
Dallas E Gilbreath Jr,
Dana M Lewis,
Daniel J Lahar,
Daniel S Fam,
Danielle Lyke,
Danny D Horner,
Darla J Christopher,
David J Leray,
Decarlos A Gomez,
Deniza Karacic,
Dr. Gopa Biswas, PhD,
Ed Gonzalez Vazquez,
Elisa M Fleming,
Elkins,
Elmina E Akwo,
Elmina E Mboh,
Elvia J Cervantes,
Emilio O Escobar,
Enspect User,
Erma Zaimova,
Fernando C Martinez,
Frans E Mercado,
Gery M Duparc,
Grant,
Grant L Davis,
Gregory A Holt,
Haley L Coleman,
Hasan A Irier, PhD,
Henry E Sanchez,
Iris C Macinnes,
Ivan E Reyes,
Jacey Roy,
Jacob W Reynolds,
Jamie M Bumpas,
Janet B Abt,
Jeffrey R Wooley,
Jennifer D Young,
Jennifer Hua,
Jennifer Owens Dowdy,
Jodi M Gatica,
Joel D Martinez,
Johnson,
Jonathan M Mcbride,
Juan D Lopez,
Judy Ellen Ciaraldi,
Kamara Tx,
Karlton T Watson,
Kenitra D Hewitt,
Khunnathee Stoner,
Kia L Copeland,
Kip J Hanks,
Kristin N Longfellow,
Latorie S Jones,
Lauren E Skokan,
Lauren M Lilly, PhD,
Lawrence C Coleman,
Leighton K Ngai,
Lisa M Puttonen,
Lisa R Jennings,
Lloyd D Payne,
Loan T Tran,
Lori A Gioia,
Lowell R Oates,
Maira P Brading,
Marc A Jackson, Jr,
Marc R Dickens,
Mariana F Baxter,
Marlene L Davis,
Martha S Baldwin,
Matthew J Gretkierewicz,
Matthew R Maddox,
Melissa D Kalik,
Merelynn Rhoten,
Michele M Falchek,
Michelle Paxon,
Monique Rac Lester,
Monique S Frazier,
Nimmy Mathews,
Patrice S Hall,
Patricia M Jacobs,
Patrick D Stone, MS,
Patty P Kaewussdangkul,
Paul E Frazier,
Pauline N Logan,
Perla M Castillo,
Phillip D Waldron,
Ramon L Gonzalez Prieto,
Rebecca C O Bryan,
Rene R Ramirez,
Rhonda L Dash,
Richard J Bashay,
Richard L Bartlett,
Richard W Berning,
Robert M Tillman,
Robert T Harris,
Rodriguez,
Ronda R Loyd Jones,
Roy Baby,
Samuel J Arsenault,
Sandra Jacquez,
Sandy J Ziegler,
Scott K Zika,
Scott R Nichols, PhD,
Scott T Ballard,
Selene T Torres,
Shannon A Lowe,
Shawn E Larson,
Shelby N Marler,
Staci G Mcallister,
State Agency,
Tamera H Hunt,
Tara A Gray,
Terrance L Thomas,
Timothy B Webb,
Timothy J Herrman,
Toby Vern H Hill,
Tracy J Washington,
Travis M Beard,
Travis S Brown,
Trina K Vick,
Verlinda A Narcisse,
William F Lagud, Jr,
Yaw O Osei,
Young M Yoon,
Zerita White
Amanda J White's Documents
Publish Date | Document Type | Title |
---|---|---|
January, 2016 | EIR | Jeffrey Whitman, MD - EIR, 2016-01-11 |
June, 2014 | EIR | David W. Brown, MD - EIR, 2014-06-20 |
August, 2011 | FDA 483 | InSite Clinical Research, LLC - Form 483, 2011-08-16 |
March, 2015 | EIR | Parexel Informatics - EIR, 2015-03-05 |
July, 2013 | FDA 483 | Covance Clinical Research Unit, Inc. - Form 483, 2013-07-02 |
August, 2013 | FDA 483 | InSite Clinical Research, LLC - Form 483, 2013-08-12 |
February, 2013 | EIR | Carter BloodCare - Alliance - EIR, 2013-02-01 |
September, 2011 | FDA 483 | Hagop M. Kantarjian, M.D. - Form 483, 2011-09-16 |
July, 2009 | EIR | Dowling ("Dow") B. Stough, IV, M.D. - EIR, 2009-07-24 |
October, 2012 | FDA 483 | Pablo J. Sanchez, M.D. - Form 483, 2012-10-22 |
February, 2013 | FDA 483 | Carter BloodCare - Alliance - Form 483, 2013-02-01 |
March, 2015 | FDA 483 | Agnieszka Jagiello-Gruszfeld, M.D., Mazurskim Centrum - Form 483, 2015-03-20 |
March, 2015 | FDA 483 | Dariusz Kowalski, M.D. - Form 483, 2015-03-13 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more